Unique ID issued by UMIN | UMIN000006224 |
---|---|
Receipt number | R000007355 |
Scientific Title | Evaluation of efficiency and safety of a new hip arthroplasty implant(AMU001)for patients with hip joint diseases |
Date of disclosure of the study information | 2011/09/01 |
Last modified on | 2014/03/28 10:12:06 |
Evaluation of efficiency and safety of a new hip arthroplasty implant(AMU001)for patients with hip joint diseases
Clinical study of a new prosthesis for total hip arthroplasty (AMU001)
Evaluation of efficiency and safety of a new hip arthroplasty implant(AMU001)for patients with hip joint diseases
Clinical study of a new prosthesis for total hip arthroplasty (AMU001)
Japan |
Osteoarthritis of the Hip, Osteo necrosis of the Femoral Head, Rheumatoid arthritis
Orthopedics |
Others
NO
This clinical trial is conducted for the patients with hip joint diseases. The efficiency and safety of the test device, a new prosthesis for total hip arthroplasty(AMU001), will be evaluated 12 months after surgery
Safety,Efficacy
Not applicable
JOA Score
Efficiency:
Radiographic assessment
Safety:
Adverse events
Radiographic assessment
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
Implantation of a hip prosthesis
20 | years-old | <= |
Not applicable |
Male and Female
(1) Inclusion criteria:
1) Osteoarthritis of the hip:
advanced or end stage
2) Osteonecrosis of the Femoral Head: Stage 3A, 3B, or 4
3) Rheumatoid arthritis:
Larsen Grade2 or greater than grade 2
(2) JOAscore<=69
(3) Patient's agreement
(4) Age>=20
(1) Patient had previously received hip prosthesis in the same hip joint.
(2) Patient received artificial joint prosthesis in lower extremity within 180 days.
(3) In the other side of the hip;
1) loosening of total hip arthroplasty or hemiarthroplasty
2) osteotomy or soft tissue release around hip joint is scheduled within one year
(4) Charnley category C
(5) Body weight>=80kg, BMI>=30
(6) Severe osteoporosis
(7) Abscess or infection around hip joint
(8) Metal allergy
(9) It is difficult to follow the hip precautions due to neurological disorder, mental illness, alcohol dependence, or drug abuse.
(10) joined other clinical trial within 90 days
(11) in pregnancy or scheduled to become pregnant during this clinical trial.
(12) it is not possible to stop to use anticoagulant or antiplatelet drug from one week before surgery.
(13) Patient who is determined to be excluded from the clinical trial due to any reasons by the study doctor.
30
1st name | |
Middle name | |
Last name | (1) Hiroshi Ito (2) Takeshi Masuda |
(1) Asahikawa Medical University Hospital
(2) Eniwa Hospital
(1) Orthopaedics (2) Orthopaedics
(1) Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, Japan (2) 2-1-1, Koganechuou, Eniwa, Hokkaido, Japan
0166-68-2511
itohiro@asahikawa-med.ac.jp
1st name | |
Middle name | |
Last name | Masaaki Kato |
National University Corporation Asahikawa Medical University
General Affairs Division
Midorigaoka-Higashi 2-1-1-1, Asahikawa, Hokkaido, Japan
0166-68-2189
sho-kenkyu@jimu.asahikawa-med.ac.jp
Asahikawa Medical University Hospital Orthopaedics
Asahikawa Medical University
Self funding
Center for Translational Research, Hokkaido University
NAKASHIMA MEDICAL CO, LTD.
NAKASHIMA MEDICAL CO, LTD.
NO
①国立大学法人旭川医科大学病院 (北海道)
②医療法人社団我汝会えにわ病院(北海道)
2011 | Year | 09 | Month | 01 | Day |
Unpublished
Completed
2011 | Year | 08 | Month | 30 | Day |
2011 | Year | 10 | Month | 01 | Day |
2014 | Year | 03 | Month | 01 | Day |
2011 | Year | 08 | Month | 24 | Day |
2014 | Year | 03 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007355